Pharma Cos. Launch 2nd Gout Antitrust Case Against Takeda
A group of pharmaceutical companies has accused Takeda Pharmaceuticals and several other drug manufacturers of entering into anti-competitive deals related to the gout drug Colcrys, launching the second federal lawsuit in...To view the full article, register now.
Already a subscriber? Click here to view full article